| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
The human transcriptome map reveals extremes in gene density, intron length, GC content, and repeat pattern for domains of highly and weakly expressed genes.
|
Genome Res
|
2003
|
4.21
|
|
2
|
Neuroblastoma: biology, prognosis, and treatment.
|
Pediatr Clin North Am
|
2008
|
2.24
|
|
3
|
Neuroblastoma: biology, prognosis, and treatment.
|
Hematol Oncol Clin North Am
|
2010
|
2.21
|
|
4
|
NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome.
|
Cell
|
2010
|
1.81
|
|
5
|
Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification.
|
Clin Cancer Res
|
2010
|
1.79
|
|
6
|
The Phox2B homeobox gene is mutated in sporadic neuroblastomas.
|
Oncogene
|
2004
|
1.18
|
|
7
|
The guardians' perspective on paediatric cancer treatment in Malawi and factors affecting adherence.
|
Pediatr Blood Cancer
|
2008
|
1.07
|
|
8
|
The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplification.
|
Int J Cancer
|
2010
|
0.95
|
|
9
|
Molecular risk stratification of medulloblastoma patients based on immunohistochemical analysis of MYC, LDHB, and CCNB1 expression.
|
Clin Cancer Res
|
2008
|
0.94
|
|
10
|
Reporting health-related quality of life scores to physicians during routine follow-up visits of pediatric oncology patients: is it effective?
|
Pediatr Blood Cancer
|
2011
|
0.90
|
|
11
|
Dickkopf-3 expression is a marker for neuroblastic tumor maturation and is down-regulated by MYCN.
|
Int J Cancer
|
2008
|
0.84
|
|
12
|
The efficacy and toxicity of SIOP preoperative chemotherapy in Malawian children with a Wilms tumour.
|
Pediatr Blood Cancer
|
2012
|
0.83
|
|
13
|
The role of the 'innovative therapies for children with cancer' (ITCC) European consortium.
|
Cancer Treat Rev
|
2010
|
0.82
|
|
14
|
Obituary of a very special doctor, Dr Jan de Kraker (October 18, 1944 to January 19, 2012).
|
J Pediatr Hematol Oncol
|
2012
|
0.79
|
|
15
|
The influence of patient reported outcomes on the discussion of psychosocial issues in children with cancer.
|
Pediatr Blood Cancer
|
2012
|
0.77
|